Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma

Overview of attention for article published in Frontiers in immunology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 54,240 followers.

New article: Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma https://t.co/OjwDQ4muj6 #kidneycancer #oncology https://t.co/qtBnbJS6n8

19 Aug 2022

Reply Repost Favourite

Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma https://t.co/ODa4q3wJCT

18 Aug 2022

Reply Repost Favourite

Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma https://t.co/WaYQ5jrJ8x https://t.co/csBXznFCZm

02 Aug 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates res…

02 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.